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Background: Recent studies suggest that lactation has long-term effects on risk for cardiovascular disease in
women, but the effects on cardiovascular mortality are less well known.
Method: In a Norwegian population-based prospective cohort study, we studied the association of lifetime duration
of lactation with cardiovascular mortality in 21,889 women aged 30 to 85 years who attended the second
Nord-Trøndelag Health Survey (HUNT2) in 1995–1997. The cohort was followed for mortality through 2010 by a
linkage with the Cause of Death Registry. Adjusted hazard ratios (HR) for death from all causes and cardiovascular
disease were calculated using Cox regression.
Results: During follow-up, 1,246 women died from cardiovascular disease. Parous women younger than 65 years
who had never lactated had a higher cardiovascular mortality than the reference group of women who had
lactated 24 months or more (HR 2.77, 95% confidence interval [CI]: 1.28, 5.99). There was some evidence of a
U-shaped association, where women who reported lactating 7–12 months had a HR of 0.55 (95% CI: 0.27, 1.09).
No clear associations were observed among women 65 years or older.
Conclusions: Excess cardiovascular mortality rates were observed among parous women younger than 65 years
who had never lactated. These findings support the hypothesis that lactation may have long-term influences on
maternal cardiovascular health.
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Cardiovascular disease is the most common cause of death
in women in all European countries and accounts for 26%
of deaths before the age of 65 [1]. Thus, it is important to
identify behaviours that may modify women’s risk of cardio-
vascular disease. Lactation is unique to women and may
affect maternal metabolic health. A growing number of
studies have shown that lactation has both short- and
long-term beneficial effects on maternal cardiovascular
risk factors, such as lipids, blood pressure, insulin and
glucose homeostasis, obesity and diabetes [2-11], and that
it may reduce the risk of cardiovascular events [12].* Correspondence: tone.natland.fagerhaug@ntnu.no
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distribution, and reproduction in any mediumEven if one might expect that the reported favourable
effects of lactation on cardiovascular risk factors would
reduce the risk of cardiovascular death, the evidence is
sparse. A recent study among Chinese textile workers
found a slightly increased risk of death from ischemic heart
disease among parous women who had never breastfed,
though no consistent trend was observed [13]. However,
the findings may not be applicable to populations with
other birth and breastfeeding characteristics.
Norway has one of the highest breastfeeding rates in
Europe, with 36% of the infants being breastfed at twelve
months [14], hence providing a population of women
that is quite suitable for studying the health effects of
lactation. Furthermore, linkage between high quality
health registries and population-based health surveys,
such as the national Cause of Death Registry and theed Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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long-term mortality follow-up studies.
To our knowledge, no previous study has examined
the association of lactation and cardiovascular mortality
in a Western general population. The purpose of this
study was to assess the long-term cardiovascular mortality
according to lifetime lactation duration in a population-
based cohort of more than 20,000 Norwegian women who
were followed prospectively for 15 years.
Methods
Study population
The Nord-Trøndelag Health Study (HUNT) is a population-
based health study aiming at the total adult popula-
tion ≥20 years of age in the county of Nord-Trøndelag,
Norway. The HUNT Study comprises a total of three sep-
arate surveys and covers the period 1984–2006. Our study
is based on data collected in the second survey (HUNT2,
1995–97). A detailed description of the data collection and
methods has been published elsewhere [15]. Briefly, the
current survey included two self-administered question-
naires and a clinical examination. The first questionnaire
was sent by mail along with an invitation to a physical
examination. The questionnaire included questions about
health and lifestyle. The participants were requested to
bring the completed questionnaire to the physical examin-
ation which included standardized measurements of height,
weight, waist and hip circumferences, and blood pressure.
Non-fasting concentrations of serum lipids were also mea-
sured. A second, more detailed questionnaire was handed
out after the examination, and should be completed at
home and returned by mail. Females were asked to
provide data on reproductive history including number
of births and corresponding lactation duration, as well
as diseases and ailments, medical treatment, lifestyle, and
socio-economic factors.
Among 47,312 women who were invited to HUNT2,
a total of 35,280 (75.5%) women participated. For the
purpose of this study, reasons for exclusions were: non-
response to the second questionnaire (n = 4,957); current
pregnancy (n = 575); age above 85 years (n = 309) or below
30 (n = 3,713); non-attendance at the clinical examination
(n = 380); self-report of myocardial infarction (n = 1), stroke
(n = 5) angina pectoris (n = 2) or diabetes (n = 31) prior to
the first birth; unknown parity (n = 139); less than one year
since their last child birth (n = 89); and unknown lactation
history (n = 3,121). This left 21,889 women as eligible
for statistical analysis, of whom 20,007 women reported
to have given birth to at least one child.
Lactation history
The second questionnaire included a self-reported lactation
history. For each birth, the women reported year of birth
and corresponding lactation duration in whole months(“How many months did you breastfeed?”). Lifetime
duration of lactation was the sum of lactation duration
for all births and was categorised into five levels (none, 1–6,
7–12, 13–23, and ≥24 months). The same categorization
scheme was used in a previous study on lactation and
long-term maternal metabolic health [11].
Mortality end points
The unique 11-digit personal identification number of
every Norwegian citizen enabled linkage of data from the
HUNT2 survey with information from the Cause of Death
Registry at Statistics Norway. Death reports are issued by
physicians and public health officers and sent to the Cause
of Death Registry. The reporting is mandatory by law.
Deaths were classified according to the International
Classification of Disease (ICD-9 and ICD-10), and cardio-
vascular disease was defined by ICD-9: 390 – 459 and
ICD-10: I00 – 99. We calculated individual person time at
risk from the date of participation in the HUNT2 Survey
as baseline and until date of death from cardiovascular
disease or from other causes, or until the end of follow-up
at December 31st 2010, whichever occurred first.
Clinical measurements
Height was measured without shoes to the nearest 1.0 cm
and weight wearing light clothing to the nearest 0.5 kg.
Body mass index was calculated as weight (kg) divided by
the squared value of height (m2). Waist and hip circum-
ferences were measured with a flexible steel band with
the participants standing upright, and the numbers were
rounded to the nearest 1.0 cm. Waist circumference was
measured horizontally at the height of the umbilicus,
and hip circumference was measured likewise at the thick-
est part of the hip [15].
Blood pressure was measured by specially trained
nurses or technicians with oscillometric Dinamap 845
XT (Critikon, Tampa, FL) after adjustment of the cuff
size according to the arm circumference. After an ini-
tial two minutes’ rest, the blood pressure was automat-
ically measured three times at intervals of one minute
[15]. In this study, we used the mean value of the sec-
ond and third measurement of systolic and diastolic
blood pressure.
The blood sample (non-fasting) drawn from all partic-
ipants was centrifuged at the screening station and, on
the same day, transported in a cooler to the laboratory.
Serum lipids were analysed at the Central Laboratory,
Levanger Hospital, using a Hitachi 911 Autoanalyser
(Hitachi, Mito, Japan), applying reagents from Boehringer
Mannheim (Mannheim, Germany). Total serum cholesterol
and triglycerides were measured by an enzymatic colori-
metric method. The day-to-day coefficients of variation
were 1.3-1.9% for total cholesterol and 0.7-1.3% for
triglycerides [15].
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Baseline characteristics of the women were evaluated by
Chi-square statistics and independent samples t-test.
We used the following cut-off points and definitions: hyper-
tension (blood pressure ≥ 140/90 mmHg or current antihy-
pertensive treatment), elevated triglycerides (>1.7 mmol/L),
diabetes (‘yes’ or ‘no’ to the question ‘Do you have or have
you had diabetes?’ or blood glucose ≥ 11.1 mmol/l), obesity
(body mass index ≥ 30 kg/m2), and abdominal obesity
(waist circumference ≥88 cm).
Cox regression using attained age as the time-scale
[16] was used to estimate hazard ratios (HR) and 95%
confidence intervals (CIs) of death from all causes and
from cardiovascular disease, first in three broad categories
of nulliparous women and never/ever lactating women, and
then more detailed in five categories of lifetime lactation
duration among parous women. As previous studies have
shown beneficial maternal metabolic effects with increasing
duration of lactation [6,11,17,18], we used women with the
longest lactation duration, i.e. ≥24 months, as a reference
category. P-values from trend-tests were estimated among
the parous women treating the categories of lactation
duration as ordinal variables in tests for trends in the
regression models.
To examine whether the effects of lactation duration
were modified by age, we stratified the analyses according
to baseline age (<65 years and ≥65 years). We also
assessed statistical interaction using a likelihood ratio
test of a product term of lactation duration and baseline
age (<65 years and ≥65 years). Age 65 was chosen as the
cut-off point since cardiovascular morbidity and mortality
increases markedly after this age in women.
All analyses were adjusted for age in the time-scale.
Potential confounders were a priori chosen based on estab-
lished associations and/or plausible biological relations with
the exposure of interest. Hence our multivariable adjusted
models included the following: education (primary school,
secondary school, college/university, and unknown),
smoking status (current, former, and never smoker) hours
of physical activity per week (no activity; < 3 hours light
or < 1 hour hard activity; >3 hours light or 1 hour hard
activity; >1 hour hard activity, and unknown), marital status
(unmarried, divorced, widowed, and married/cohabiting),
and parity (1, 2, 3 or ≥ 4 children).
Furthermore, we explored whether the association between
lactation and cardiovascular mortality could be mediated by
some conventional cardiovascular risk factors by adding
body mass index, systolic and diastolic blood pressure, use of
antihypertensive medication, triglycerides, total cholesterol,
and diabetes to the fully adjusted model one at a time.
In supplementary analyses we restricted the sample to
women aged 45 to 64 years in order to avoid misclassifica-
tion of lactation due to changes in parity and thus lactation
history after participation in HUNT2.Departure from the proportional hazard assumptions
was evaluated by Schoenfeld residuals [19]. All statis-
tical tests were two-sided, and all analyses were per-
formed using STATA software, release 11 for Windows
(Stata Corp., College Station, Texas, USA).
Ethical approval
The study was approved by the Regional Committee for
Medical and Health Research Ethics and by the Norwegian
Data Inspectorate. Written informed consent was given by
all participants.
Results
Baseline characteristics of the 21,889 women in our cohort
are presented in Table 1. The majority of the 20,007 parous
women (96.7%) had breastfed one or more children.
Mean and median lifetime duration of lactation among
women who had breastfed were 16.5 (SD 12.2) and 14.0
(Interquartile range [IQR] 14.0) months. There were some
differences in parity and lactation habits between
women younger than 65 years and women 65 years or
older (Table 2). There were more nulliparous women
in the oldest age group. On the other hand, older women
were more likely to have four or more births, and to re-
port lifetime duration of lactation ≥ 24 months compared
to the younger women.
During a median follow-up of 14.5 years (297,972
person-years), a total of 3,130 (14.3%) women died and
of these 1,246 (39.8%) died from cardiovascular disease.
Among these women, there were 449 deaths from ischemic
heart disease and 353 deaths from stroke.
There was evidence that the effect of lactation duration
was modified by age at baseline (P-values for interaction:
0.008 for total death and 0.003 for death from cardiovascu-
lar disease). Thus, all analyses were stratified by age above
or below 65 years.
Table 3 shows age-stratified analyses of all-cause and
cardiovascular mortality for never and ever lactating
women, as well as for nulliparous women. Among parous
women younger than 65 years, those who reported never
lactating had an adjusted HR of 2.86 (95% CI: 1.51, 5.39)
for death from cardiovascular disease compared with
women who had ever lactated. Restricting the sample to
women aged 45 to 64 years strengthened the association
(HR 3.15, 95% CI: 1.66, 6.00) (Additional file 1: Table S1).
Among women 65 years and older, we found no clear
association between lifetime lactation history and
cardiovascular mortality.
Among parous women younger than 65 years, we further
explored the association across five categories of lactation
duration (Figure 1). Approximately one in five women
(22.5%) reported lifetime duration of lactation of 24 months
or longer. Women who reported that they had never
lactated had an adjusted HR of 2.77 (95% CI: 1.28, 5.99)
Table 1 Baseline characteristics of women in the HUNT2 Survey, Norway, 1995–97 (n = 21,889)
Variablesa Ever lactated Never lactated Nulliparous
(n = 19,350) (n = 657) (n = 1,882)
Mean age, years (SD) 52.1 (14.1) 52.5 (12.5) 55.9 (16.8)
Age at delivery of first child, yrs 23.4 (4.1) 24.4 (5.2) -
Lifetime lactation duration, months, median (IQR)b 14 (14) - -
Systolic blood pressure, mmHg, mean (SD) 135.9 (23.0) 139.5 (22.4) 141.6(25.1)
Diastolic blood pressure, mmHg, mean (SD) 79.5 (11.9) 82.1 (11.9) 81.1 (12.4)
Cholesterol, mmol/L, mean (SD) 6.0 (1.3) 6.2 (1.1) 6.2 (1.4)
Triglycerides, mmol/l, mean (SD) 1.6 (0.99) 1.7 (0.98) 1.6 (1.0)
Body mass index, kg/m2, mean (SD) 26.4 (4.5) 27.6 (4.9) 26.6 (5.0)
Waist –hip ratio, mean (SD) 0.80 (0.06) 0.81 (0.06) 0.80 (0.06)
Parity,
Para 1, n (%) 1,793 (9.3) 175 (26.6) -
Para 2, n (%) 7,305 (37.4) 260 (39.6) -
Para 3, n (%) 6,187 (32.0) 151 (23.0) -
Para 4 or greater, n (%) 4,065 (21.0) 71 (10.8) -
College/university education, n (%)c 3,659 (18.9) 86 (13.1) 409 (21.7)
Never smokers, n (%) 9,345 (48.6) 248 (37.8) 1,085 (58.6)
High physical activityd,e, n (%) 3,468 (17.9) 86 (13.1) 311 (16.5)
Unmarried/divorced, n (%) 3,081 (15.9) 133 (20.2) 972 (51.8)
Cardiovascular diseasef, n (%) 1,070 (5.5) 38 (5.8) 142 (7.6)
Hypertensiong, n (%) 7.935 (41.0) 326 (49.6) 953 (50.6)
Elevated triglyceridesf, n (%) 6,286 (32.5) 257 (39.2) 612 (32.4)
Diabetes, n (%) 523 (2.7) 31 (4.7) 78 (4.1)
Obesity, n (%) 3,655 (18.9) 186 (28.3) 406 (21.6)
Abdominal obesityg, n (%) 5,369 (27.8) 257 (39.2) 512 (27.3)
Abbreviations: HUNT2 The second Nord-Trøndelag Health Survey, SD standard deviation.
aContinuous variables presented as mean (SD), categorical variables presented as number (%) in each category of lactation.
bAmong women who had lactated (n = 19 350).
cNumber of women in the category “unknown” in the total sample of women: n = 781 (ever lactated), n = 30 (never lactated), and n = 157 (nulliparous).
dHigh physical activity defined as ≥1 hour hard physical activity per week.
eNumber of women in the category “unknown ”in the total sample of women: n = 1,976 (ever lactated), n = 75 (never lactated), and n = 309 (nulliparous).
fCardiovascular disease = history of angina, stroke or myocardial infarction.
gHypertension defined as bloodpressre ≥ 140/90 mmHg or the use of antihypertensive medication.
fElevated triglycerides defined as triglycerides >1.7 mmol/L.
gAbdominal obesity defined as waist circumference ≥88 cm.
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women who reported ≥24 months of lifetime duration
of lactation (Figure 1). We did not find a linear rela-
tionship across the categories of lifetime duration of
lactation (P-trend 0.8). However, there was some evidence
of a U-shaped association, where women who reported
lactating 7–12 months had an adjusted HR of 0.55
(95% CI: 0.27, 1.09). In the restricted sample of parous
women aged 45 to 64 years, those who reported no lac-
tation had an adjusted HR of 3.03 (95% CI: 1.38, 6.70)
while those who had lactated 7–12 months had an
adjusted HR of 0.45 (95% CI: 0.21, 0.97) for death from
cardiovascular disease compared with women who had
lactated ≥24 months (Additional file 2: Figure S1).Furthermore, we explored whether body mass index,
systolic and diastolic blood pressure, use of antihypertensive
medication, triglycerides and total cholesterol could
mediate the association between lactation duration and
cardiovascular mortality. The analyses showed that the
excess mortality was attenuated after adjustment for these
factors and that body mass index, systolic and diastolic
blood pressure, use of antihypertensive medication and
diabetes contributed to the attenuation (Table 4).
Discussion
In this large study of 21,889 women with no report of
cardiovascular disease prior to their first delivery, we
found that cardiovascular mortality was almost three
Table 2 Distribution of parity and lifetime lactation
duration among women <65 years and women ≥65 years
in the HUNT2 Survey, Norway, 1995–97 (n = 21,889)
Variables Women < 65 years Women ≥ 65 years
(n = 16,672) (n = 5,217)
Parity
Nulliparous, n (%) 1,172 (7.0) 710 (13.6)
Para 1, n (%) 1,546 (9.3) 422 (8.1)
Para 2, n (%) 6,329 (38.0) 1,236 (23.7)
Para 3, n (%) 5,125 (30.7) 1,213 (23.3)
Para 4, n (%) 2,500 (15.0) 1,636 (31.4)
Lactation (n = 15,500) (n = 4,507)
No lactation 532 (3.4) 125 (2.8)
1 – 6 months, n (%) 3,286 (21.2) 699 (15.5)
7 – 12 months, n (%) 3,951 (25.5) 981 (21.8)
13 – 24 months, n (%) 4,662 (30.1) 1,278 (28.4)
≥ 24 months, n (%) 3,069 (19.8) 1,424 (31.6)
Abbreviations: HUNT2 The second Nord-Trøndelag Health Survey.
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who had never lactated compared to women of the same
age who reported lifetime lactation duration of ≥24 months.
There was also some evidence of a U-shaped associ-
ation, where women who reported lifetime duration of
7–12 months had almost half the risk of women who
had lactated ≥24 months.
The present study adds further evidence that lactation is
associated with long-term beneficial effects on the mothers’
metabolic health, and supports earlier reports that haveTable 3 Hazard ratios and 95% CIs for all causes and cardiova
women by two categories of lifetime lactation duration, strat
No. of
persons Person-years
All causes
No. of
deaths
Mortality
ratea
Simple
modelb
HR
Women <65 years
Total 16,672 237,286 670 28
Ever lactated 14,968 213,175 587 28 1.00
Never lactated 532 7,491 33 44 1.44
Nulliparous 1,172 16,620 50 30 1.16
Women ≥65 years
Total 5,217 60,685 2,460 405
Ever lactated 4,382 51,588 1,987 385 1.00
Never lactated 125 1,480 53 358 1.05
Nulliparous 710 7,617 420 551 1.24
Abbreviations: HUNT2 The second Nord-Trøndelag Health Survey, HR hazard ratio, C
aIncidence per 10,000 person-years.
bAdjusted for maternal age.
cAdjusted for age, smoking status, physical activity, education, marital status and pa
The HUNT2 Survey, 1995-2010.shown an inverse relationship with visceral adiposity
[10,20,21], hypertension [7], metabolic syndrome [4,18,22],
type 2 diabetes [6,8,23], as well as other risk factors
for cardiovascular disease [10,11,17] and myocardial
infarction [12].
The only other study that has explored the association
of lactation and cardiovascular mortality found results
similar to ours [13]. This study from China suggested
that parous women who did not breastfeed had a slightly
increased risk of death from ischemic heart disease. By
comparison, our study indicated a strong association
between lactation and cardiovascular disease mortality.
However, whereas the substantial sample size and large
number of deaths in the Chinese study allowed the in-
vestigators to distinguish between different subgroups
of cardiovascular mortality, this was not possible in the
present one. Furthermore, it should be noted that the two
studies differ in study design and sample characteristics.
Whereas our study sample consisted of women from a
general population in Central Norway, the Chinese study
used textile workers in the largest city in the world. Thus,
the study populations differed in age distribution, birth pat-
terns, breastfeeding practice, disease distribution, longevity,
health status, access to health care, level of education, and
other socioeconomic and demographic variables.
Possible mechanisms that may explain our findings
include several short- and long-term hormonal responses
related to reproduction and lactation. Pregnancy induces
significant changes in well-known risk factors for cardiovas-
cular disease that could increase the risk of both cardiovas-
cular morbidity and mortality. They include accumulationscular disease mortality in nulliparous and parous
ified by age (n = 21,889)
Cardiovascular disease
Fully adjusted
modelc
No. of
deaths
Mortality
ratea
Simple
modelb
Fully adjusted
modelc
HR 95% CI HR HR 95% CI
115 5
1.00 Referent 98 5 1.00 1.00 Referent
1.33 0.93, 1.89 11 15 2.85 2.86 1.51, 5.39
0.96 0.69, 1.33 6 4 0.82 0.41 0.16, 1.04
1,131 186
1.00 Referent 914 177 1.00 1.00 Referent
1.01 0.77, 1.33 26 176 1.14 1.11 0.77, 1.69
1.20 1.06, 1.36 191 251 1.21 1.20 1.00, 1.44
I confidence interval.
rity.
Figure 1 Risk of death from cardiovascular disease associated with five categories of lifetime lactation duration for women <65 years
(n = 15,500) with lifetime lactation duration ≥ 24 months as the reference category: Hazard ratios and 95% confidence intervals.
Adjusted for age, smoking status, physical activity, education, marital status and parity. Number of women in each category of lifetime duration of
breastfeeding, with number of deaths in brackets, 0 months: n = 532 (11), 1–6 months: n = 3,286 (24), 7–12 months: n = 3,951 (15), 13–23 months:
n = 4,662 (38), ≥ 24 months: n = 3,069 (21).
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genic lipid profile and insulin resistance [26], all of which
may pose a risk to the mother’s health. Although the
evidence regarding the effects of parity on maternal
cardiovascular morbidity and mortality is conflicting
[27,28], the hypothesis that lactation may affect the risk of
metabolic disease by facilitating a faster resetting of the
maternal metabolism after pregnancy has been proposed
[29]. Our study indicates that the same hypothesis could
be extended to include cardiovascular mortality as well.
We have previously reported an inverse and apparent
dose-dependent association of lactation and body mass
index, triglycerides, total and low density lipoprotein
cholesterol, glucose, and blood pressure among women
aged 50 years or younger in the current study populationTable 4 Hazard ratios of cardiovascular mortality by two cate
in parous women < 65 years (n = 15,500)a
Adjustment for
Age, smoking status, physical activity, education, marital status and parity
Age, smoking status, physical activity, education, marital status, parity +body
Age, smoking status, physical activity, education, marital status, parity, + systo
blood pressure, and use of antihypertensive medication
Age, smoking status, physical activity, education, marital status, parity, + trigly
Age, smoking status, physical activity, education, marital status, parity, + total
Age, smoking status, physical activity, education, marital status, parity, + diab
Age, smoking status, physical activity, education, marital status, parity, + body
and diastolic blood pressure, use of antihypertensive drugs, triglycerides, tota
Abbreviations: HUNT2 The second Nord-Trøndelag Health Survey, HR hazard ratio, C
aOf 15,500 women, 109 died of cardiovascular disease.
The HUNT2 Survey, 1995-2010.[11]. One explanation for these favourable effects of lacta-
tion could be that it drains calories as well as cholesterol
from the lactating mother, thereby explaining the lower
body mass index and lower cholesterol levels observed.
Obesity [30] and dyslipidemia [31] are both considered
independent risk factors for cardiovascular mortality,
hence the cardiovascular mortality risk could be reduced by
the favourable effect of lactation on the body mass index
and cholesterol levels per se. The association between lacta-
tion duration and cardiovascular mortality in our study was
slightly attenuated after adjustment for body mass, systolic
and diastolic blood pressure, use of antihypertensive medi-
cation, and diabetes. This could suggest that the association
may partly be mediated by these factors. Furthermore,
a lower body mass index could also decrease serum lipidsgories of lifetime lactation duration (ever vs. never)
HR (95% CI)
2.86 (1.51, 5.39)
mass index 2.78 (1.47, 5.27)
lic and diastolic 2.76 (1.45, 5.22)
cerides 2.92 (1.54, 5.51)
cholesterol 2.89 (1.53, 5.45)
etes 2.72 (1.44, 5.13)
mass index, systolic
l cholesterol, and diabetes
2.63 (1.39, 4.99)
I confidence interval.
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homeostasis. A lower body mass index could thereby
mediate the inverse association between lactation and
lipids, blood pressure, diabetes risk, and ultimately with
cardiovascular mortality.
However, given that both the amount and regional
distribution [32,33] of fat mobilization seem to vary with
time since delivery in lactating mothers, more complex
mechanisms may be involved. It has been suggested that
lactation induces alterations in the hypothalamic-pituitary-
adrenal axis that could explain the increased mobilization
of adipose tissue stores as well as influence what region of
the body the fat is mobilized from [10].
The pituitary hormone oxytocin has been linked to the
favourable short term effects of lactation on blood pressure
[34]. Although circulating oxytocin has a very short half-
life, even the long-term effects of lactation on blood pres-
sure [22,35,36] have been attributed to oxytocin. Although
the mechanisms are still unclear, it has been hypothesized
that oxytocin induces a decrease in cortisol secretion and
adrenocorticotropic hormone and an increase in central
α2-adrenergic activity, which in turn may produce more
lasting favourable effects on blood pressure [22,35].
Lactation may also influence several other pituitary
hormones [37] and induce even long-term changes in
the hypothalamic-pituitary axis [38]. A wide range of
hormones may be involved in the mechanisms behind the
association between lactation and cardiovascular mortality.
Prolactin, vasopressin, estrogen, relaxine, progesterone,
leptin, cortisol, thyroid-stimulating hormone and prolactin-
inhibiting factor are either involved in, or influenced by,
lactation or even produced by the mammary gland [39-42].
Prolactin has been associated with incident hypertension in
post-menopausal women [43] and accelerated preclinical
atherosclerosis [44]. Lactation was also associated with a
decrease in prolactin levels in a prospective cohort study
[45]. One may speculate that lactation triggers a complex
hormonal cascade that induces both short-term and long-
term effects on maternal metabolic health, making several
hormones work together on a number of different factors
like blood pressure regulation, lipolysis and lipogenesis, glu-
cose homestasis and insulin secretion, lipid homeostasis,
and inflammatory processes. This could occur as an inter-
action between reproductive and metabolic hormones, and
potentially via metabolic pathways yet not unveiled.
We found an association between lactation and cardio-
vascular mortality only in women younger than 65 years.
There are several possible explanations for this observation.
The biological effect of lactation may wane with time,
as other age-related cardiovascular risk factors become
more prevalent. Moreover, other risk factors for cardiovas-
cular disease, such as obesity [46] show stronger associa-
tions with mortality in younger than in older age groups,
possibly reflecting either selective survival or inability tocapture relative differences in mortality in older age groups
[47]. Finally, more women in the oldest age group reported
higher parity. One may speculate that if higher parity
increases cardiovascular mortality, the beneficial effects of
lactation may not be sufficient to outweigh the risk related
to grand multiparity.
The strengths of our study include the large sample size,
wide age range, high rates of both study participation and
lactation, standardised measurements, and the long follow-
up time from 1995–97 through 2010. Combined with the
national end-point registry that provides reliable data
on deaths, and the personal identification number allocated
to each citizen, our study provides a unique opportunity
to study the association between lactation duration and
cardiovascular mortality.
Some limitations should be noted. First, women who
breastfeed their children may possibly have better health,
healthier lifestyles and higher socioeconomic status than
those who do not [48], and therefore have lower risk of
cardiovascular mortality. Breastfeeding rates are very
high among Norwegian women, and fewer than 4% of
our entire sample had never lactated. Thus, the women
who had lactated and those who had not may have differed
in terms of major confounders. However, adjustment for
factors known to be associated both with lactation duration
and risk of cardiovascular mortality did not materially
change the estimated associations. In women younger
than 65 years, we observed the lowest risk of cardio-
vascular mortality among those who reported lifetime
duration of lactation of 7 – 12 months. This could reflect
an optimal duration of lactation, although residual con-
founding by unmeasured and unknown factors, including
diet and pre-pregnancy and early postpartum health status
cannot be ruled out. Furthermore, lifetime duration of lac-
tation is largely influenced by the number of childbirths,
and thus it may be difficult to distinguish the effect of
lactation from the effect of parity.
Additionally, we cannot rule out the issue of reverse
causation. Obesity [49] and type 1 diabetes [50] have been
linked to difficulties with initiating lactation as well as
lactation duration. Furthermore, women with preeclamp-
sia breastfed less than women without the condition [51],
and reduced breastfeeding rates in the early postpartum
period have been reported in women with polycystic ovary
syndrome [52]. Hence, shorter lactation duration could be
a marker for an already existing metabolic disease, which
in turn could influence whether the women lactate and
how long they did so. Unfortunately, with the exception of
the women’s self reports of diabetes prior to the birth
of their first child, we had no other data available on
metabolic disorders prior to or during their pregnan-
cies. The women who reported diabetes prior to their
first child birth were excluded from our analyses, and
reverse causation due to diabetes is therefore unlikely.
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were not available, we adjusted only for body mass index
at study participation in supplementary analyses. That
gave no substantial change in our estimates. It should be
noted, however, that obesity may either precede [49] or
follow lactation practices [10,53], and one may argue that
body mass index measured at study participation would
act as an intermediate factor.
Moreover, lactation was assessed retrospectively. Never-
theless, maternal recall of lactation seems to be fairly valid
and reliable [54], even decades after weaning [55]. Indeed,
in a population of Norwegian women breastfeeding
duration was recalled quite accurately 20 years after
mothers gave birth [56]. Even so, we cannot rule out the
possibility of misclassification. Still, it is unlikely to be
differential for cardiovascular risk factors. Our observed
estimates are therefore likely to be conservative.
Lastly, during the follow-up of 15 years, the baseline
variables parity and lactation history may have changed.
Some of the women who reported no lactation at base-
line might have given birth to another child and lactated
during the follow-up period. If the associations between
lactation and cardiovascular disease are causal, our es-
timates are most likely underestimations. This notion
is supported by the observed strengthening of the estimates
when we restricted the analyses to women whose parity
and lactation history were unlikely to have changed during
follow-up (i.e. aged 45–64 years).
Conclusion
In this long-term follow-up, excess cardiovascular mortality
rates were observed among parous women younger than
65 years who had never lactated, and the risk was lowest
among women who reported lifetime duration of lactation
of 7–12 months. Whether lactation acts as a marker of
health, as a protective factor per se, or through complex
hormonal interactions is unclear. Nevertheless, if substan-
tiated, our findings might suggest the need for vigorously
promoting these benefits of breastfeeding, especially in
countries, where the rate of initiation is low and the
breastfeeding duration is short. Future studies should
include maternal metabolic factors before and during
pregnancy that may affect both breastfeeding practices and
later maternal cardiovascular health in order to elucidate
the observed associations further.
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